Johnson & Johnson Inks $4B Sale of Ortho Arm to Carlyle

Johnson & Johnson (JNJ) on Monday signed off on a $4 billion bid from private-equity giant Carlyle Group (CG) to acquire the blue-chip company’s blood-testing business.

The agreement represents the end of a months-long bidding process for the ortho-clinical diagnostics business, which makes blood-screening equipment, lab blood tests and other exams that screen for HIV.